Glenmark Pharmaceuticals Inc., USA is voluntarily recalling 2,031,480 tubes of Mupirocin Ointment, USP, 2% (22 g). This prescription antibiotic medication is being recalled because it was found to be subpotent, meaning it contains less of the active ingredient than is required by safety standards. A subpotent antibiotic may not effectively treat the skin infection for which it was prescribed, potentially leading to a prolonged infection.
If the ointment does not have the full required strength, it may fail to clear the bacterial skin infection properly. This can lead to worsening symptoms, the spread of the infection, or the development of antibiotic resistance.
You have 2 options:
Manufactured by Glenmark Pharmaceuticals, Ltd., India for Glenmark Pharmaceuticals Inc., USA.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.